Perinatal outcome in pregnancies with a positive serum screening for Down's syndrome due to elevated levels of free β-human chorionic gonadotropin

Ultrasound in Obstetrics and Gynecology

Volumn 13, Issue 1, 1999, Pages 58-62

  Palacio, M ^a   Jauniaux, E ^a,b   Kingdom, J ^a   Dell, E ^a   Sheldrake, A ^a   Rodeck, C H ^a  

^a UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Biochemistry; Down's screening; Fetal; Pregnancy; Ultrasound

Indexed keywords

CHORIONIC GONADOTROPIN BETA SUBUNIT;

ARTICLE; BLOOD FLOW VELOCITY; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DOPPLER FLOWMETER; DOWN SYNDROME; FEMALE; FETUS OUTCOME; HUMAN; KARYOTYPING; MAJOR CLINICAL STUDY; PATIENT COUNSELING; PLACENTA CIRCULATION; PRENATAL SCREENING; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; RISK; SERODIAGNOSIS; UTERINE ARTERY; WAVEFORM;

BLOOD FLOW VELOCITY; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; DOWN SYNDROME; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; GESTATIONAL AGE; HUMANS; ILIAC ARTERY; INFANT, NEWBORN; KARYOTYPING; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY OUTCOME; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; ULTRASONOGRAPHY, DOPPLER, COLOR; ULTRASONOGRAPHY, PRENATAL; UTERUS;

EID: 0033017116     PISSN: 09607692     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1469-0705.1999.13010058.x     Document Type: Article

References (21)

1. Wald NJ, Kennard A, Densen JW, Cuckle HS, Chard T, Butler L. Antenatal maternal serum screening for Down's syndrome: Results of a demonstration project. Br Med J 1992;305:391-4
2. Sorensen TK, Williams MA, Zingheim RW, Clement SJ, Hickok DE. Elevated second trimester human chorionic gonadotropin and subsequent pregnancy-induced hypertension. Am J Obstet Gynecol 1993;169:834-8
3. Lieppman RE, Williams MA, Cheng EY, Resta R, Zingheim R, Hickok DE, Luthy DA. An association between elevated levels of human chorionic gonadotropin in the midtrimester and adverse pregnancy outcome. Am J Obstet Gynecol 1993;168:1852-7
4. Tanaka M, Natori M, Kohno H, Ishimoto H, Kobayashi T, Nozawa S. Fetal growth in patients with elevated maternal serum hCG levels. Obstet Gynecol 1993;81:341-3
5. Hsu CD, Chan DW, Iriye B, Johnson TRB, Hong SF, Repke JT. Elevated serum human chorionic gonadotropin as evidence of secretory response in severe preeclampsia. Am J Obstet Gynecol 1994;170:1135-8
6. Benn PA, Horne D, Briganti S, Rodis J, Clive JM. Elevated second-trimester maternal serum hCG alone or in combination with elevated alpha-fetoprotein. Obstet Gynecol 1996;87:217-22
7. Jauniaux E, Gulbis B, Tunkel S, Ramsay B, Campbell S, Meuris S. Maternal serum testing for alpha-fetoprotein and human chorionic gonadotropin in high-risk pregnancies. Prenat Diagn 1996;12:1129-35
8. Muller F, Savery L, Le Fiblec B, Bussieres L, Ndayizamba G, Colau JC, Giraudet P. Maternal serum human chorionic gonadotropin level at fifteen weeks is a predictor for preeclampsia. Am J Obstet Gynecol 1996;175:37-40
9. Morssink LP, Heringa MP, Beekhuis JR, De Wolf BTHM, Mantingh A. The association between hypertensive disorders of pregnancy and abnormal second-trimester maternal serum levels of hCG and alpha-fetoprotein. Obstet Gynecol 1997;89:666-70
10. Ashour AMN, Lieberman ES, Wilkins Haug LE, Repke JT. The value of elevated second-trimester β-human chorionic gonadotropin in predicting development of pre-eclampsia. Am J Obstet Gynecol 1997;176:438-42
11. Pahal GS, Jauniaux E. Maternal serum biochemical screening for pregnancy complications other than aneuploidy. Curr Opin Obstet Gynecol 1997;9:379-86
12. Aristidou A, Van den Hof MC, Campbell S, Nicolaides K. Uterine artery Doppler in the investigation of pregnancies with raised maternal serum alpha-fetoprotein. Br J Obstet Gynaecol 1990;97:431-5
13. Bromley B, Frigoletto FD, Harlow BL, Pauker S, Benacerraf BR. The role of Doppler velocimetry in the structurally normal second-trimester fetus with elevated levels of maternal serum α-fetoprotein. Ultrasound Obstet Gynecol 1994;4:377-80
14. Konachak PS, Bernstein IM, Capeless L. Uterine artery Doppler velocimetry in the detection of adverse obstetric outcomes in women with unexplained elevated maternal serum α-fetoprotein levels. Am J Obstet Gynecol 1995;173:1115-19
15. Bower S, Bewley S, Campbell S. Improved prediction of preeclampsia by two-stage screening of uterine arteries using the early diastolic notch and color Doppler imaging. Obstet Gynecol 1993;82:78-83
16. Kloosterman GJ. On intrauterine growth: The significance of prenatal care. Int J Gynecol Obstet 1970;8:895-912
17. Hsieh TT, Hung TH, Hsu JJ, Shau WY, Su CW, Hsieh FJ. Prediction of adverse perinatal outcome by maternal serum screening for Down syndrome in an Asian population. Obstet Gynecol 1997;89:937-40
18. Harrington K, Goldfrad C, Carpenter RG, Campbell S. Transvaginal uterine and umbilical artery Doppler examination of 12-16 weeks and the subsequent development of preeclampsia and intrauterine growth retardation. Ultrasound Obstet Gynecol 1997;9:94-100
19. Spencer K. Ethnic differences in outcome serum screening for Down's syndrome. Br Med J 1996;312:1041
20. Eskenazi B, Fenster L, Sidney S. A multivariate analysis of risk factors for preeclampsia. J Am Med Assoc 1991;266:237-41
21. Morssink LP, Heringa MP, Beekhuis JR, De Wolf BTHM, Mantingh A. The HELLP syndrome: Its association with unexplained elevation of MSAFP and MShCG in the second trimester. Prenat Diagn 1997;17:601-6